Document Type : Research articles

Authors

1 Assistant Professor, Oral Medicine Department, Dental School, Semnan University of Medical Sciences, Semnan, Iran

2 Associate Professor, Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran; Associate Professor, Hematology-Oncology Department, Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran

3 Assistant Professor, Oral and Maxillofacial Pathology Department, Dental School, Semnan University of Medical Sciences, Semnan, Iran

4 Dental Student, Student Research Committee, Dental Faculty, Semnan University of Medical Sciences, Semnan, Iran

5 Dental Medicine Student, Dental medicine Faculty, Pavol Jozef Safarik University, Kosice, Slovakia

Abstract

Background: Although Knowledge of the side effects of cancer treatments is crucial for everyone, it is more vital for patients' companions. Since they can significantly improve patients' attitudes towards cancer treatments and help them tolerate the disease; Objectives: In this study, we aimed to examine the level of knowledge and attitudes of companions about dental considerations and oral complications related to chemotherapy and radiotherapy.
Methods: In this cross-sectional study, a questionnaire was provided to companions at Kowsar Hospital in Semnan University, Iran, in October 2021. A total of 176 companions were selected by simple sampling method. Inclusion criterion consisted of the companions who were most of the time alongside the patients. The researcher-designed questionnaire included three sections: demographic variables, knowledge of and attitude toward dental considerations, and oral complications related to chemotherapy and radiotherapy (15 and 4 items, respectively). The relationship between knowledge and attitude with variables (e.g., gender, education level, duration of the treatment, and the location of the cancer) was investigated.
Results: Overall, 176 companions participated in this research. A total of 152 (86.4%) individuals had low to moderate knowledge (score 7-14), and only 6 (3.4%) companions had high knowledge (score 15-19). Around 74 (42%) individuals had moderate attitude scores, and 98 (55.7%) had high attitude scores. Companions knowledge scores increased significantly with higher education and having head and neck cancer patients. Moreover, companions attitude scores decreased significantly with the age and duration of patients treatments and increased significantly with higher education and having gastrointestinal cancer patients.
Conclusion: The level of knowledge and attitude of companions was low to moderate about chemotherapy- and radiotherapy-induced oral complications and dental considerations. Therefore, improving the comprehensive education of this group is required.

Keywords

  1. Mousavi SM, Gouya MM. Cancer incidence and mortality in Iran. Ann Oncol. 2009;20(3):556-63. doi: 10.1093/annonc/mdn642. [PubMed: 19073863]
  2. Radha A, Namrata O. Knowledge and Practice on Oral Care among the Patients Receiving Chemotherapy. Am J Cancer Res. 2014;2:9-13. doi: 10.12691/ajcp-2-1-4.
  3. Rothenberg SM, Ellisen LW. The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest. 2012;122(6):1951-7. doi: 10.1172/jci59889. [PubMed: 22833868]
  4. Wyss A, Hashibe M, Chuang SC, Lee YC, Zhang ZF, Yu GP, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the international head and neck cancer epidemiology consortium. Am J Epidemiol. 2013;178(5):679-90. doi: 10.1093/aje/kwt029. [PubMed: 23817919]
  5. Tolentino EdS, Centurion BS, Ferreira LH, Souza AdP, Damante JH, Rubira-Bullen IRF. Oral adverse effects of head and neck radiotherapy: literature review and suggestion
  6. of a clinical oral care guideline for irradiated patients. J
  7. Appl Oral Sci. 2011;19(5):448-54. doi: 10.1590/s1678-77572011000500003. [PubMed: 21986648]
  8. Torabi Parizi M, Kalantari M, Ghavidel F. Evaluation of head and neck cancer patients’ knowledge regarding complications of chemotherapy and radiotherapy in patients referring to Kerman university of medical sciences treatment centers. J Dent Med. 2018;31(2):83-90.
  9. Ruiqing D, Guowen L. Use of a smartphone medical app improves complications and quality of life in patients with nasopharyngeal carcinoma who underwent radiotherapy and chemotherapy. Med Sci Monit. 2018;24:6151-6. doi: 10.12659/MSM.908146. [PubMed: 30178780]
  10. Anvari K, Alvandi F, Bazri F, Hosseini S, Moghadam S, et al. Evaluation of educational requirements among iranian cancer patients undergoing radiotherapy. Radiother Oncol. 2013;1(2):65-8.
  11. Piredda M, Rocci L, Gualandi R, Petitti T, Vincenzi B, De Marinis MG. Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy. Eur J Oncol Nurs. 2008;12(2):120-6. doi: 10.1016/j.ejon.2007.10.004. [PubMed: 18294913]
  12. Little J, Miller C, Rhodus N. Little and falace's dental management of the medically compromised patient. United States of America: Mosby; 2017.
  13. Jalili Sadrabad M, Sardarifard Moghadam L, Ghorbani R, Salehi Zeinabadi M, Sohanian S. A Survey of the awareness of patients, physicians and dentists in the city of Semnan towards the fields of the oral and Maxillofacial medicine specialists. JMIS. 2021;7(2):38-46. doi: 10.52547/jmis.7.2.38.
  14. Haghpanah S, Amini M, Kherad M, Sadeghimehr R. Knowledge and practice of patients with breast cancer about complication of chemotherapy. J Res Med Sci. 2006;6(2):28-32.
  15. Hofman M, Morrow G, Ranson S, Jean-Pierre P, Dakhil S, Moore T, et al. Chemotherapy-naïve cancer patients’ expectations of developing treatment-related side effects: A URCC CCOP study of 670 patients from community
  16. practices. J Clin Oncol. 2006;24(18):8509-17. doi: 10.1200/jco.2006.24.18_suppl.8509.
  17. AkhavanKarbasi M, Forat M, Ahadian H, JaliliSadrabad M. Evaluating Baremoom Mouthwash efficacy in treatment of chemotherapy-induced Mucositis. JSSU. 2016;23(12):1220-32.
  18. AkhavanKarbassi MH, Yazdi MF, Ahadian H, SadrAbad MJ. Randomized doubleblind placebocontrolled trial of Propolis for oral Mucositis in patients receiving chemotherapy for head and neck cancer. Asian Pac J Cancer Prev. 2016;17(7):3611-4. [PubMed: 27510017]